Advanced search
Publication Cover
Cytotherapy Volume 12, 2010 - Issue 2
Journal homepage
15
Views
1
CrossRef citations to date
0
Altmetric
Research Article

CD34+ cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine

David H. Mckenna Jr University of Minnesota, Minneapolis, Minnesota, USACorrespondence[email protected]
,
Sheryl Adams University of Minnesota, Minneapolis, Minnesota, USA
,
Darin Sumstad University of Minnesota, Minneapolis, Minnesota, USA
,
Therese Sumstad University of Minnesota, Minneapolis, Minnesota, USA; *Present address: Minnesota Oncology, Saint Paul, MN, USA
,
Diane Kadidlo University of Minnesota, Minneapolis, Minnesota, USA
,
Adrian P. Gee Baylor College of Medicine, Houston, Texas, USA
,
April Durett Baylor College of Medicine, Houston, Texas, USA
,
Debe Griffin University of Pittsburgh, Pittsburgh, Pennsylvania, USA
,
Albert Donnenberg University of Pittsburgh, Pittsburgh, Pennsylvania, USA
,
David Amrani Baxter Healthcare Corporation, Deerfield, Illinois, USA
,
Deborah Livingston Baxter Healthcare Corporation, Deerfield, Illinois, USA
,
Robert Lindblad The EMMES Corporation, Rockville, Maryland, USA
,
Deborah Wood The EMMES Corporation, Rockville, Maryland, USA
&
David Styers The EMMES Corporation, Rockville, Maryland, USA
 show all
Pages 170-177 | Received 13 Aug 2009, Accepted 10 Nov 2009, Published online: 18 Jan 2010

References

  • Appelbaum FR. Hematopoietic cell transplantation at 50. New Engl J Med. 2007;357:1472–5.
  • Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, . Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.
  • Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: moving toward a stem cell-based therapy. World J Gastroenterol. 2008;14:4616–26.
  • García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R, Menendez P. Mesenchymal stem cells and their use as a cell replacement therapy and disease modeling tool. J Cell Mol Med. 2008;12:2552–65.
  • Reffelmann T, Könemann S, Kloner RA. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair. J Am Coll Cardiol. 2009; 53:305–8.
  • Capiod JC, Tournois C, Vitry F, Sevestre MA, Daliphard S, Reix T, . Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product. Vox Sang. 2009;96:256–65.
  • Moviglia GA, Varela G, Brizuela JA, Moviglia Brandolino MT, Farina P, Etchegaray G, . Case report on the clinical results of a combined cellular therapy for chronic spinal cord injured patients. Spinal Cord. 2009;46:499–503.
  • Bartunek J, Vanderheyden M, Vandekerckhove B, Mansour S, De Bruyne B, De Bondt P, . Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation. 2005;112(suppl 9): 1178–83.
  • Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
  • Hildebrandt M, Serke S, Meyer O, Ebell W, Salama A. Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield. Transfusion. 2000;40:507–12.
  • Kasow KA, Sims-Poston L, Eldridge P, Hale GA. CD34+ hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Biol Blood Marrow Transplant. 2007;13:608–14.
  • Rowley SD, Loken M, Radich J, Kunkle LA, Mills BJ, Gooley T, . Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system. Bone Marrow Transplant. 1998;21:1253–62.
  • Gryn J, Shadduck RK, Lister J, Zeigler ZR, Raymond JM. Factors affecting purification of CD34+ peripheral blood stem cells using the Baxter Isolex 300i. J Hematother Stem Cell Res. 2002;11:719–30.
  • Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion. 2005;45:1909–16.
  • Flores AI, McKenna DH, Montalbán MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pair-wise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion. 2009;49:636–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.